A team at Children’s National Research and Innovation Campus is working on something new that could change the way we pinpoint pain, and how effectively we treat it. The technology could give hope to ...
Treatment with the highly selective NaV1.8 pain signal inhibitor suzetrigine met the primary endpoint with a statistically significant and clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback